{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:57Z","timestamp":1786118877966,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/mnm.0b013e3282fda205","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T03:05:45Z","timestamp":1212030345000},"page":"642-648","source":"Crossref","is-referenced-by-count":4,"title":["Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism"],"prefix":"10.1097","volume":"29","author":[{"given":"Sherif Mohamed","family":"El Refaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"Shawkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210212","first-page":"624","article-title":"Application of radioactive iodine in therapy of Graves' disease [abstract]","volume":"21","author":"Hertz","year":"1942","journal-title":"J Clin Invest"},{"key":"R2-10-20210212","first-page":"1038","article-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-10-20210212","first-page":"379","article-title":"Treatment of thyrotoxicosis","volume":"48","author":"Iagaru","year":"2007","journal-title":"J Nucl Med"},{"key":"R4-10-20210212","first-page":"313","article-title":"Efficiency of treatment and monitoring of ablative radioiodine therapy for hyperthyroidism: a DGH centre study","volume":"44","author":"Safe","year":"1990","journal-title":"Br J Clin Pract"},{"key":"R5-10-20210212","first-page":"348","article-title":"Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes","volume":"26","author":"Hedley","year":"1992","journal-title":"J R Coll Physicians Lond"},{"key":"R6-10-20210212","first-page":"175","article-title":"Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism","volume":"88","author":"Franklyn","year":"1995","journal-title":"Q J Med"},{"key":"R7-10-20210212","first-page":"3488","article-title":"The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective randomized study","volume":"86","author":"Andrade","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-10-20210212","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/105072502753522365","article-title":"The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial","volume":"12","author":"Braga","year":"2002","journal-title":"Thyroid"},{"key":"R9-10-20210212","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/01.mnm.0000183795.59097.42","article-title":"High pre-therapy Tc99m-pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in 131I iodine therapy in Graves' disease","volume":"26","author":"Zantut-Wittmann","year":"2005","journal-title":"Nucl Med Commun"},{"key":"R10-10-20210212","first-page":"3611","article-title":"Radioiodine treatment of hyperthyroidism: prognostic factors for outcome","volume":"86","author":"Allahabadia","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-10-20210212","first-page":"347","article-title":"Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication","volume":"24","author":"Ghadban","year":"2003","journal-title":"Saudi Med J"},{"key":"R12-10-20210212","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bmj.39114.670150.BE","article-title":"Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials","volume":"334","author":"Walter","year":"2007","journal-title":"BMJ"},{"key":"R13-10-20210212","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/jcem.83.2.4538","article-title":"Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism","volume":"83","author":"Imseis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-10-20210212","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1210\/jc.2004-0247","article-title":"Propylthiouracil before 131I therapy of hyperthyroid disease: effect on cure rate evaluated by a randomized clinical trial","volume":"88","author":"Bonnema","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-10-20210212","first-page":"1073","article-title":"High dose 131I therapy for the treatment of hyperthyroidism caused by Graves' disease","volume":"87","author":"Alexander","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-10-20210212","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2362.2004.01349.x","article-title":"Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome","volume":"34","author":"Walter","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"R17-10-20210212","first-page":"28","article-title":"Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake","volume":"8","author":"Ruchala","year":"2005","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"R18-10-20210212","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1475-097X.2006.00666.x","article-title":"Radioiodine therapy in hyperthyroid disease: poorer outcome in patients with high 24\u2009hours radioiodine uptake","volume":"26","author":"Kristoffersen","year":"2006","journal-title":"Clin Physiol Funct Imaging"},{"key":"R19-10-20210212","first-page":"225","article-title":"Treatment of Graves' hyperthyroidism: prognostic factors for outcome","volume":"28","author":"Alfadda","year":"2007","journal-title":"Saudi Med J"},{"key":"R20-10-20210212","first-page":"3257","article-title":"Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome","volume":"81","author":"Murakami","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-10-20210212","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/ENDO:25:1:55","article-title":"Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome","volume":"25","author":"Erem","year":"2004","journal-title":"Endocrine"},{"key":"R22-10-20210212","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.1995.tb02039.x","article-title":"Is calculation of the dose in radioiodine therapy of hyperthyroidism worthwhile?","volume":"43","author":"Jarlov","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R23-10-20210212","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2362.1995.tb01547.x","article-title":"Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131-iodine activity. Results from a prospective, randomized, multicentre study","volume":"25","author":"Peters","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"R24-10-20210212","first-page":"499","article-title":"Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism","volume":"84","author":"Bogazzi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-10-20210212","first-page":"1049","article-title":"Radioactive iodine in the treatment of Graves' disease","volume":"23","author":"Al-Kaabi","year":"2002","journal-title":"Saudi Med J"},{"key":"R26-10-20210212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jc.2002-020805","article-title":"A randomized comparison of radioiodine doses in Graves' hyperthyroidism","volume":"88","author":"Leslie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-10-20210212","first-page":"158","article-title":"Comparative evaluation of two fixed doses of 185 and 370\u2009MBq I131, for the treatment of Graves' disease resistant to antithyroid drugs","volume":"8","author":"Esfahani","year":"2005","journal-title":"Hell J Nucl Med"},{"key":"R28-10-20210212","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/00006231-200011000-00014","article-title":"Clinical outcome after standardized versus dosimetric radioiodine treatment of hyperthyroidism: an equivalence study","volume":"21","author":"Kok","year":"2000","journal-title":"Nucl Med Commun"},{"key":"R29-10-20210212","first-page":"411","article-title":"Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease","volume":"32","author":"Nordyke","year":"1991","journal-title":"J Nucl Med"},{"key":"R30-10-20210212","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2265.2004.02152.x","article-title":"Long-term follow up study of radioiodine treatment of hyperthyroidism","volume":"61","author":"Metso","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R31-10-20210212","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/cbr.2005.20.218","article-title":"Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism","volume":"20","author":"Grosso","year":"2005","journal-title":"Cancer Biother Radiopharm"},{"key":"R32-10-20210212","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00259-006-0092-8","article-title":"Outcome of radioiodine therapy without, on or 3 days off carbimazole: a prospective interventional three-group comparison","volume":"33","author":"Walter","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R34-10-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0038-1625922","article-title":"Radioiodine therapy of Graves' disease. A dosimetric comparison of various therapy regimens of antithyroid agents","volume":"40","author":"Urbannek","year":"2001","journal-title":"Nuklearmedizin"},{"key":"R35-10-20210212","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00259-002-0877-3","article-title":"Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome","volume":"29","author":"Reinhardt","year":"2002","journal-title":"Eur J Nucl Med"},{"key":"R36-10-20210212","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1530\/eje.0.1460767","article-title":"Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis","volume":"146","author":"Ahmad","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"R37-10-20210212","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/thy.1997.7.247","article-title":"Treatment of Graves' hyperthyroidism with radioactive iodine: results of a prospective randomized study","volume":"7","author":"Peters","year":"1997","journal-title":"Thyroid"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006231-200807000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:01:39Z","timestamp":1786035699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-200807000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e3282fda205","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}